221884-63-5,
Fmoc-alpha-allyl-DL-glycine,
FMOC-DL-allylglycine,
Fmoc-DL-Allyglycine,
Fmoc--allyl-DL-Gly-OH,
MFCD02259489,
Fmoc-2-amino-4-pentenoic acid;Fmoc-allylglycine,
(S)-N-Fmoc-allyl-glycine,
FMOCDLallylglycine,
AK-33322,
AC1N2Q97,
SCHEMBL15585491,
CTK8B2931,
2-(9H-fluoren-9-ylmethoxycarbonylamino)pent-4-enoic Acid,
DTXSID40398796,
KS-00002B3P,
2-Allyl-N-Fmoc-DL-glycine, 98%,
ANW-41375,
AKOS005073844,
FCH5342348,
RP16741,
RTR-010452,
SS-3924,
VZ36572,
VZ36581,
ACM221884635,
BBV-38207329,
TR-010452,
FT-0681831,
N-FLUORENEMETHOXYCARBONYL-D-ALLYL GLYCINE,
N-FLUORENEMETHOXYCARBONYL-L-ALLYL GLYCINE,
F2147-6513,
2-(9H-Fluorene-9-ylmethoxycarbonylamino)-4-pentenoic acid,
2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-enoic acid,
4-Pentenoic acid,2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,
Fmoc-Gly(allyl)-OH,
Fmoc-D-Allylglycine,
Fmoc-L-Allylglycine,
fmoc-d-gly(allyl)-oh,
Fmoc-alpha-allyl-DL-Gly-OH,
CID4052587,
146549-21-5,
170642-28-1,
2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pent-4-enoic acid,